10.4291/wjgp.v11.i1.1 23 GongG.WangP.DingW.ZhaoY.LiJ
Your goals If your goal is modest appetite control, improved post-meal glucose or a small, gradual weight change, start with low-cost, low-risk options such as Metamucil and lifestyle changes
GLP-1 agonists as a class offer substantial benefits, including improved glycemic control, weight reduction, and cardiovascular protection, that millions of Americans have come to rely on, and semaglutide brands such as Ozempic and Wegovy have emerged as the drugs of choice for most patients
We see a range of consumers that are essentially just taking the medication, letting it do its thing, and not really embracing any sort of lifestyle change
The main concern is that reduced appetite could lead to inadequate calorie intake, which might affect milk supply